Prot #IMSA101-101: Phase I/IIA Safety and Efficacy Study of IMSA101 in Patients with Advanced Treatment-Refractory Malignancies

Project: Research project

Project Details

StatusActive
Effective start/end date12/13/19 → 12/13/22

Funding

  • Precision Oncology, LLC (Prot #IMSA101-101)
  • ImmuneSensor Therapeutics, Inc. (Prot #IMSA101-101)
View all
View less